Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Depression 3 Breast Neoplasms 2 Anxiety Disorders 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hospice 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Gynecologic Cancer 1 Gastrointestinal Neoplasms 1 Emotional Regulation 1 Colonic Neoplasms 1 Advanced Cancer 1 Acute Pain 1

Interventions

Rituximab 295 Cyclophosphamide 240 Peripheral Blood Stem Cell Transplantation 114 fludarabine phosphate 110 Filgrastim 93 Etoposide 85 Radiotherapy 81 Lenalidomide 79 Vincristine 78 Prednisone 77 Mycophenolic Acid 66 Doxorubicin 61 Cyclosporine 59 Whole-Body Irradiation 58 Bendamustine Hydrochloride 58 Melphalan 57 Tacrolimus 53 Busulfan 51 fludarabine 50 Cytarabine 48 obinutuzumab 46 Methotrexate 45 Antilymphocyte Serum 43 Bortezomib 42 Methylprednisolone 37 Carmustine 37 sargramostim 36 ibritumomab tiuxetan 32 ibrutinib 30 Dexamethasone 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma, Follicular × Psychotherapy × Clear all

NCT06225232 2025-03-19

PSI_CUD

McMaster University

Phase 2 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡